ZNFX1 and colorectal carcinoma: Associated with aggressive tumor phenotype and poor prognosis in CRC. Knockdown inhibits cell proliferation and invasion in vitro, and tumorigenesis and metastasis in vivo. ZNFX1-AS1 works as a ceRNA for miR-144, inhibiting to EZH2